United States · Exchanges & live quotes · Nasdaq
Calytrix Bio To Be Bought By Lilly In Up To $1.5 Bln Cash Deal
Detailed summary
(RTTNews) - Calytrix Bio, Inc., a biotechnology company focused on myeloproliferative neoplasms or MPNs, announced Monday its definitive agreement to be acquired by drug major Eli…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)


